Effect of OTC on GSH-Px activity of hRBCs.

<p>Data represent the mean ± SD of three independent experiments.</p

Effect of OTC on ATPase activity of hRBCs.

<p>Data represent the mean ± SD of three independent experiments.</p

Scanning electron micrographs of hRBCs incubated in PBS containing OTC.

<p>The OTC concentration for A, B and C is 0, 1.0×10⁻⁵ mol L⁻¹ and 5.0×10⁻⁵ mol L⁻¹, respectively.</p

Effect of OTC on SOD activity of hRBCs.

<p>Data represent the mean ± SD of three independent experiments.</p

The distribution map of integrated fluorescence intensity (representing glutathione content) of hRBCs.

<p>A, hRBCs only; B, hRBCs incubating with 6×10⁻⁵ mol L⁻¹ OTC.</p

Absorption spectra.

<p>(a) supernatant for the hRBCs suspension after centrifugation; (b) hemolysate (incubated with ultrapure water); (c) supernatant for the hRBCs incubated with 1.1×10⁻⁴ mol/L OTC after centrifugation; (d) hemolysate incubated with 4×10⁻⁴ mol/L OTC. a, b, c and d have the same number of hRBCs obtained from the same blood sample.</p

Optical and fluorescence images of hRBCs at 60× magnification (GSH derivatized by NDA).

<p>A and B are the hRBCs under bright field and epifluorescence illumination condition, respectively. C is the derived hRBCs under epifluorescence illumination condition.</p

Effect of OTC on CAT activity of hRBCs.

<p>Data represent the mean ± SD of three independent experiments.</p

Effect of OTC on GSH content of hRBCs.

<p>Data represent the mean ± SD of three independent experiments.</p